GoodRx Holdings Inc [GDRX] stock is trading at $6.52, down -0.46%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The GDRX shares have lost -3.26% over the last week, with a monthly amount drifted -5.64%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
GoodRx Holdings Inc [NASDAQ: GDRX] stock has seen the most recent analyst activity on April 10, 2024, when KeyBanc Capital Markets upgraded its rating to a Overweight but kept the price target unchanged to $9 for it. Previously, Wells Fargo upgraded its rating to Overweight on March 25, 2024, and elevated its price target to $10. On March 01, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $10 on the stock. Leerink Partners started tracking the stock assigning a Outperform rating and suggested a price target of $8 on February 26, 2024. BofA Securities downgraded its rating to a Underperform and reduced its price target to $4.50 on January 02, 2024. DA Davidson upgraded its rating to Buy for this stock on August 10, 2023, but kept the price target unchanged to $9.50. In a note dated July 31, 2023, TD Cowen upgraded an Outperform rating on this stock and boosted its target price from $6.50 to $12.
GoodRx Holdings Inc [GDRX] stock has fluctuated between $4.14 and $9.37 over the past year. Currently, Wall Street analysts expect the stock to reach $16.08 within the next 12 months. GoodRx Holdings Inc [NASDAQ: GDRX] shares were valued at $6.52 at the most recent close of the market. An investor can expect a potential return of 146.63% based on the average GDRX price forecast.
Analyzing the GDRX fundamentals
GoodRx Holdings Inc [NASDAQ:GDRX] reported sales of 750.26M for the trailing twelve months, which represents a growth of 6.81%. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at -0.02%, Pretax Profit Margin comes in at -0.07%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.01 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.87.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.39 points at the first support level, and at 6.25 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.71, and for the 2nd resistance point, it is at 6.89.
Ratios To Look Out For
For context, GoodRx Holdings Inc’s Current Ratio is 7.12. Also, the Quick Ratio is 7.12, while the Cash Ratio stands at 5.49. Considering the valuation of this stock, the price to sales ratio is 3.43, the price to book ratio is 3.37.
Transactions by insiders
Recent insider trading involved Wagner Scott,, that happened on Nov 30 ’23 when 21652.0 shares were purchased., Wagner Scott completed a deal on Nov 29 ’23 to buy 26348.0 shares. Meanwhile, Wagner Scott bought 4157.0 shares on Nov 28 ’23.
